Artiva Biotherapeutics, Inc. (ARTV) vs Cabaletta Bio, Inc. (CABA)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and Cabaletta Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CABA
Cabaletta Bio, Inc.
$2.08HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ARTV vs CABA
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)CABA -70.5% (-45.7%/yr)ARTV compounded faster over this window
ARTV CABA
ARTV vs CABA: by the numbers
- •ARTV is the larger company ($349M vs $339M market cap).
Metrics side by side
Valuation
| Metric | ARTV | CABA |
|---|---|---|
| P/B ratio | 1.00 | 1.61 |
Profitability
| Metric | ARTV | CABA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -26.14% | -86.10% |
| ROIC | -27.16% | -85.56% |
Growth (annualized)
| Metric | ARTV | CABA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -28.71% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.